Clinical

Dataset Information

A single-center, single-arm, observational study of fruquinitinib combined with capecitabine and PD-1 in neoadjuvant therapy for colorectal cancer


ABSTRACT: Interventions: Experimental group:Furoquantinib combined with capecitabine and PD-1 Primary outcome(s): pathologic complete response, pCR;ORR Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 105641 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR